Silvia Jesús

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi et al. · Nature Communications · 2021 · 204 citations · Full text

Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

Sonia Moreno–Grau, Itziar de Rojas, Isabel Hernández et al. · Alzheimer s & Dementia · 2019 · 171 citations · Full text

Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

Kimberley J. Billingsley, Inês A. Barbosa, Sara Bandrés‐Ciga et al. · npj Parkinson s Disease · 2019 · 158 citations · Full text

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

Diego Santos‐García, T. de Deus Fonticoba, E. Suárez Castro et al. · Parkinsonism & Related Disorders · 2019 · 128 citations

Quality Of Life, Health Sciences, Psychiatry +14

Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

Regina H. Reynolds, Juan A. Botía, Mike A. Nalls et al. · npj Parkinson s Disease · 2019 · 110 citations · Full text